Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
A key highlight will be Brenntag’s qualified amino acids portfolio
Jaypirca is making waves in the fight against B-cell malignancies
The Unit is approved by major regulators like EMA, Europe; Health Canada, Anvisa, Brazil and TGA, Australia
Adzynma, approved for both adults and children with cTTP, is a recombinant enzyme therapy designed to replace the deficient ADAMTS13 enzyme
Subscribe To Our Newsletter & Stay Updated
